Choice Defines QALYs A US Valuation of the EQ-5D-5L

被引:41
|
作者
Craig, Benjamin M. [1 ]
Rand, Kim [2 ,3 ]
机构
[1] Univ S Florida, Dept Econ, 4202 E Fowler Ave,CMC206A, Tampa, FL 33620 USA
[2] Univ Oslo, Dept Hlth Management & Hlth Econ, Oslo, Norway
[3] Akershus Univ Hosp, Hlth Serv Res Ctr, Lorenskog, Norway
基金
美国国家卫生研究院;
关键词
quality-adjusted life years; patient preference; choice behavior; health valuation; cost-utility analyses; value of life; quality of life; patient reported outcome measures; TIME TRADE-OFF; SUBJECTIVE HEALTH OUTCOMES; UNITED-STATES; VALUE SET; PREFERENCE RESEARCH; VALUES; TTO; DURATION; ADULTS; MODEL;
D O I
10.1097/MLR.0000000000000912
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The 5-level version of the EQ-5D (EQ-5D-5L) was introduced as an improvement on the original 3-level version (EQ-5D-3L). To date, 6 country-specific value sets have been published for EQ-5D-5L and 9 US value sets have been published for other instruments. Our aims were to (1) produce EQ-5D-5L values on a quality-adjusted life year (QALY) scale from the perspective of US adults and (2) compare them with US EQ-5D-3L values and the other country-specific EQ-5D-5L values. Methods: In 2016, 8222 US respondents from all 50 states and Washington, DC completed an online survey including a discrete choice experiment with 20 paired comparisons. Each comparison asked respondents, "Which do you prefer?" regarding a pair of alternatives described using EQ-5D-5L and lifespan attributes. On the basis of more than 50 choices on each of the 3160 pairs, we estimated EQ-5D-5L values on a QALY scale and compared them with the US EQ-5D-3L values and the other country-specific EQ-5D-5L values. Results: Ranging from -0.287 (55555) to 0.992 (11121) on a QALY scale, the estimated EQ-5D-5L values were similar to the US EQ-5D-3L values. Compared with the US EQ-5D-3L values, the values exhibited greater sensitivity and specificity and higher correlation with the EQ-5D-5L values of other countries, particularly England. Conclusions: Like previous US valuation studies, this study produced nationally representative EQ-5D-5L values on a QALY scale. The results further demonstrate the advantages of the EQ-5D-5L over its 3-level predecessor as a preference-based summary measure of health-related quality of life from the perspective of US adults.
引用
收藏
页码:529 / 536
页数:8
相关论文
共 50 条
  • [11] Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study
    Al-jedai, Ahmed
    Almudaiheem, Hajer
    Al-Salamah, Tareq
    Aldosari, Muath
    Almutairi, Abdulaali R.
    Almogbel, Yasser
    AlRuthia, Yazed
    Althemery, Abdullah U.
    Alluhidan, Mohammed
    Roudijk, Bram
    Purba, Fredrick Dermawan
    Awad, Nancy
    O'jeil, Rita
    VALUE IN HEALTH, 2024, 27 (05) : 552 - 561
  • [12] Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach
    Ramos-Goni, Juan M.
    Pinto-Prades, Jose L.
    Oppe, Mark
    Cabases, Juan M.
    Serrano-Aguilar, Pedro
    Rivero-Arias, Oliver
    MEDICAL CARE, 2017, 55 (07) : E51 - E58
  • [13] Scale and rate heterogeneity in the EQ-5D-5L valuation
    Jumamyradov, Maksat
    Craig, Benjamin M.
    Jakubczyk, Michal
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2024, 22 (01)
  • [14] RETRACTED: The EQ-5D-5L Valuation Study in Egypt (Retracted Article)
    Al Shabasy, Sahar A.
    Abbassi, Maggie M.
    Finch, Aureliano Paolo
    Baines, Darrin
    Farid, Samar F.
    PHARMACOECONOMICS, 2021, 39 (05) : 549 - 561
  • [15] A Program of Methodological Research to Arrive at the New International EQ-5D-5L Valuation Protocol
    Oppe, Mark
    Devlin, Nancy J.
    van Hout, Ben
    Krabbe, Paul F. M.
    de Charro, Frank
    VALUE IN HEALTH, 2014, 17 (04) : 445 - 453
  • [16] Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments
    Augustovski, Federico
    Belizan, Maria
    Gibbons, Luz
    Reyes, Nora
    Stolk, Elly
    Craig, Benjamin M.
    Tejada, Romina A.
    VALUE IN HEALTH, 2020, 23 (07) : 880 - 888
  • [17] Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets
    van Hout, Ben
    Janssen, M. F.
    Feng, You-Shan
    Kohlmann, Thomas
    Busschbach, Jan
    Golicki, Dominik
    Lloyd, Andrew
    Scalone, Luciana
    Kind, Paul
    Pickard, A. Simon
    VALUE IN HEALTH, 2012, 15 (05) : 708 - 715
  • [18] EQ-5D-3L and EQ-5D-5L population norms for Thailand
    Kangwanrattanakul, Krittaphas
    Krageloh, Christian U.
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [19] United States Valuation of EQ-5D-5L Health States Using an International Protocol
    Pickard, A. Simon
    Law, Ernest H.
    Jiang, Ruixuan
    Pullenayegum, Eleanor
    Shaw, James W.
    Xie, Feng
    Oppe, Mark
    Boye, Kristina S.
    Chapman, Richard H.
    Gong, Cynthia L.
    Balch, Alan
    Busschbach, Jan J. V.
    VALUE IN HEALTH, 2019, 22 (08) : 931 - 941
  • [20] Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary
    Rencz, Fanni
    Brodszky, Valentin
    Gulacsi, Laszlo
    Golicki, Dominik
    Ruzsa, Gabor
    Pickard, A. Simon
    Law, Ernest H.
    Pentek, Marta
    VALUE IN HEALTH, 2020, 23 (09) : 1235 - 1245